Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Close this folderSection III - Disease-Specific Reviews
Open this folder and view contentsChapter VII - Asthma
Open this folder and view contentsChapter VIII - Cancer (Palliative care)
Close this folderChapter IX - Depression
View the document1. Research methods: measurement of adherence and sampling
View the document2. Rates of adherence
View the document3. Predictors of adherence
View the document4. Interventions to improve adherence
View the document5. Clinical implications and need for further research
View the document6. References
Open this folder and view contentsChapter X - Diabetes
Open this folder and view contentsChapter XI - Epilepsy
Open this folder and view contentsChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Open this folder and view contentsChapter XIII - Hypertension
Open this folder and view contentsChapter XIV - Tobacco smoking cessation
Open this folder and view contentsChapter XV - Tuberculosis
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book

Chapter IX - Depression

Depressive disorder is one of the most prevalent forms of mental illness, and is of major public health importance (1). It is characterized by abnormal and persistent low mood, accompanied by other symptoms including sleep disturbance, loss of appetite, suicidal thoughts, impaired concentration and attention, guilt and pessimism. Symptoms vary in severity, and the pattern of illness can range from an isolated and relatively mild episode, through recurrent episodes of moderate severity, to chronic and persistent severe illness. Owing to its prevalence, and to health system factors, primary care practitioners see most of the patients with depression and few are referred to specialist psychiatric services, even when they are readily available.

Although psychological treatments of proven efficacy are available for the management of depression, the most common form of treatment worldwide is antidepressant medication. For patients with a definitive diagnosis of depression, pharmacotherapy guidelines advocate that treatment should continue for at least 6 months following remission of symptoms. Furthermore, for patients who have suffered two or more episodes of significant depression within 5 years, long-term preventive treatment is suggested (2).

The clinical effectiveness of drug therapies for depression is limited by two groups of factors; patient adherence to the recommended protocol, and under-diagnosis and/or suboptimal treatment by primary care doctors. Both groups of factors appear to be relatively common, but the focus here is on adherence. However, the diagnosis and treatment cannot be ignored as they are likely to interact with, or to mediate, adherence.

This chapter discusses research methods, the overall prevalence of adherence, predictors of adherence and the efficacy of interventions designed to improve adherence. A literature search was made using Medline (1990 - 2001). A total of 287 publications were identified and evaluated.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017